Profile of Serum Folate Levels in Various Severity Degrees of Psoriasis Vulgaris Patients at Murni Teguh Memorial Hospital Medan

Natascya Putri Siburian; Rudyn Reymond Panjaitan; Joseph Partogi Sibarani

Authors

Natascya Putri Siburian Medical Study Program, Faculty of Medicine, Universitas HKBP Nommensen Medan
Rudyn Reymond Panjaitan Department of Dermatology and Venereology, Faculty of Medicine, Universitas HKBP Nommensen Medan
Joseph Partogi Sibarani Department of Internal Medicine, Faculty of Medicine, Universitas HKBP Nommensen Medan

Keywords:

Psoriasis vulgaris, folic acid serum level

Abstract

Psoriasis vulgaris is a chronic inflammatory disease characterized by keratinocyte proliferation and excessive immune system activation. Folic acid plays a role in DNA synthesis and cell division processes. Keratinocyte hyperproliferation in psoriasis can affect serum folic acid levels, but previous studies have shown varying results. The aim of this study was to determine the serum folic acid level profile in patients with various degrees of psoriasis vulgaris severity at Murni Teguh Memorial Hospital in Medan. This was a cross-sectional study with a sample size of 11 respondents at Murni Teguh Memorial Hospital in Medan. The results showed that the majority of respondents were in the early-to-late adulthood age group (54.5%) with an average serum folate level of 9.1 ng/mL. Based on gender, the majority of respondents were female (63.6%) with an average serum folate level of 9.5 ng/mL. Based on the severity of vulgaris psoriasis, most respondents were in the mild category (72.7%) with an average serum folic acid level of 9 ng/mL, while those in the moderate category (27.3%) had an average level of 8 ng/mL. It can be concluded that all respondents (100%) in this study had serum folic acid levels in the normal range.

References

Alaya F, Sampogna F, Romano G V. The impact of psoriasis on work-related problems: a multicenter cross-sectional survey. Eur Acad Dermatology Venereol. 2014;28(1):1623–32.

Branisteanu DE, Cojocaru C, Diaconu R, Porumb EA, Alexa AI. Update on the etiopathogenesis of psoriasis (review). Spandidos Publ. 2022;23(201):1–13.

Chen C, Liu S, Liu J, Zheng Z, Zheng Y. No causal effect of genetically determined circulating homocysteine levels on psoriasis in the european population: evidence from a mendelian randomization study. Front Immunol [Internet]. 2023;14(2):1–9. Available from: 10.3389/fimmu.2023.1288632

Damiani G, Bragazzi NL, Aksut CK, Wu D, Alicandro G. The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study. Front Med. 2021;8(1):1–12.

Du CJ, Ye JW, Zhao YC. Serum folate levels and the risk of psoriasis: evidence from observational study and mendelian randomization. Br J Nutr. 2025;1(1):1–20.

Iskandar IY., Parisi R, Griffiths CE. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184(1):243–58.

Jacoeb TNA. Psoriasis. In: Menaldi SLS, editor. Ilmu penyakit kulit dan kelamin. 7th ed. Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2016. p. 213–22.

Kimak-Pielas A, Robak E, Zajdel R. Demographics, disease characteristics, and treatment patterns of patients with plaque psoriasis treated with biological drugs: the experience of a single-centre study in poland. J Clin Med. 2024;7647(13):1–14.

Leonard C, See K, Gallo G, McKean-Matthews M, Zhang Y. Psoriasis severity assessment combining physician andpatient reported outcomes: the optimal psoriasis assessment tool. Dermatol Ther. 2021;2021;11(1):1249–1263.

Levak MT, Pluzaric V, Krajina I. Serum levels of homocysteine in young psoriasis patients naïve for conventional systemic and biologic therapy. Med Sci. 2020;543(50):17–24.

Papp KA, Gniadecki R, Beecker J. Psoriasis prevalence and severity by expert elicitation. Dermatol Ther (Heidelb. 2021;11(1):1053–64.

Putra FA, Rahayu FM, Wahdini M. Profile of psoriasis vulgaris in waled general hospital, cirebon, indonesia: a retrospective study (january 2020-december 2023). GHMJ (Global Heal Manag Journal). 2025;8(1):102–11.

Samburskaya O V., Kalinchenko SY, Batkaeva N V. Biochemical pathways of metabolic disorders in psoriasis. Juvenis Sci. 2021;7(6):6–16.

Sharaf ESFA, Ghanem BM, Marzouk HF, Aziz YEMA El. Serum homocysteine, folic acid and vitamin B12 levels in patients with psoriasis vulgaris. Egypt J Hosp Med. 2022;88(1):3304–9.

Shen F, Duan Z, Li S. Factors associated with a better treatment efficacy among psoriasis patients: a study based on decision tree model and logistic regression in shanghai, china. BMC Public Health. 2024;1934(24):1–12.

Shibal-Nafakh M, Atiyah IJ, Salih MM Al, Mohammedkadimal-Hattab, Al-Essa JS. Evaluation of serum levels of folic acid, vitamin B12 and homocysteine in patients with chronic plaque psoriasis in Iraqi patients. Ann Trop Med Public Heal [Internet]. 2021;24(6):512–22. Available from: http://doi.org/10.36295/ASRO.2021.24612

Thanita V. Insidensi dan profil penyakit psoriasis di rs martha friska multatuli medan periode januari-desember 2022. Medicinus. 2022;36(2):9–12.